Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Dietary salt intake and mortality in patients with type 2 diabetes.

Ekinci EI, Clarke S, Thomas MC, Moran JL, Cheong K, MacIsaac RJ, Jerums G.

Diabetes Care. 2011 Mar;34(3):703-9. doi: 10.2337/dc10-1723. Epub 2011 Feb 2.

2.

The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes.

Thomas MC, Moran J, Forsblom C, Harjutsalo V, Thorn L, Ahola A, Wadén J, Tolonen N, Saraheimo M, Gordin D, Groop PH; FinnDiane Study Group.

Diabetes Care. 2011 Apr;34(4):861-6. doi: 10.2337/dc10-1722. Epub 2011 Feb 9.

3.

Prediction of cardiovascular events, diabetic nephropathy, and mortality by albumin concentration in a spot urine sample in patients with type 2 diabetes.

Viana LV, Gross JL, Camargo JL, Zelmanovitz T, da Costa Rocha EP, Azevedo MJ.

J Diabetes Complications. 2012 Sep-Oct;26(5):407-12. doi: 10.1016/j.jdiacomp.2012.04.014. Epub 2012 Jun 6.

PMID:
22677793
4.

Correlation between increased urinary sodium excretion and decreased left ventricular diastolic function in patients with type 2 diabetes mellitus.

Kagiyama S, Koga T, Kaseda S, Ishihara S, Kawazoe N, Sadoshima S, Matsumura K, Takata Y, Tsuchihashi T, Iida M.

Clin Cardiol. 2009 Oct;32(10):569-74. doi: 10.1002/clc.20664.

5.

Orosomucoid in urine predicts cardiovascular and over-all mortality in patients with Type II diabetes.

Christiansen MS, Hommel E, Magid E, Feldt-Rasmussen B.

Diabetologia. 2002 Jan;45(1):115-20. Erratum in: Diabetologia 2002 Mar;45(3):459.

PMID:
11845230
6.

Estimation of salt intake by urinary sodium excretion in a Portuguese adult population and its relationship to arterial stiffness.

Polónia J, Maldonado J, Ramos R, Bertoquini S, Duro M, Almeida C, Ferreira J, Barbosa L, Silva JA, Martins L.

Rev Port Cardiol. 2006 Sep;25(9):801-17. English, Portuguese.

7.

Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular and all-cause mortality in patients with type 2 diabetes (ZODIAC-31).

Riphagen IJ, Boertien WE, Alkhalaf A, Kleefstra N, Gansevoort RT, Groenier KH, van Hateren KJ, Struck J, Navis G, Bilo HJ, Bakker SJ.

Diabetes Care. 2013 Oct;36(10):3201-7. doi: 10.2337/dc12-2165. Epub 2013 Jun 11.

8.

Postprandial blood glucose predicts cardiovascular events and all-cause mortality in type 2 diabetes in a 14-year follow-up: lessons from the San Luigi Gonzaga Diabetes Study.

Cavalot F, Pagliarino A, Valle M, Di Martino L, Bonomo K, Massucco P, Anfossi G, Trovati M.

Diabetes Care. 2011 Oct;34(10):2237-43. doi: 10.2337/dc10-2414.

9.

Visit-to-visit variability in blood pressure strongly predicts all-cause mortality in patients with type 2 diabetes: a 5·5-year prospective analysis.

Hsieh YT, Tu ST, Cho TJ, Chang SJ, Chen JF, Hsieh MC.

Eur J Clin Invest. 2012 Mar;42(3):245-53. doi: 10.1111/j.1365-2362.2011.02574.x. Epub 2011 Aug 5.

PMID:
21815887
10.

Estimation of salt intake by 24 h urinary sodium excretion in a representative sample of Spanish adults.

Ortega RM, López-Sobaler AM, Ballesteros JM, Pérez-Farinós N, Rodríguez-Rodríguez E, Aparicio A, Perea JM, Andrés P.

Br J Nutr. 2011 Mar;105(5):787-94. doi: 10.1017/S000711451000423X. Epub 2010 Oct 25.

PMID:
20969815
11.

Depression and increased mortality in diabetes: unexpected causes of death.

Lin EH, Heckbert SR, Rutter CM, Katon WJ, Ciechanowski P, Ludman EJ, Oliver M, Young BA, McCulloch DK, Von Korff M.

Ann Fam Med. 2009 Sep-Oct;7(5):414-21. doi: 10.1370/afm.998.

12.

Variation of fasting plasma glucose: a predictor of mortality in patients with type 2 diabetes.

Lin CC, Li CI, Yang SY, Liu CS, Chen CC, Fuh MM, Chen W, Li TC.

Am J Med. 2012 Apr;125(4):416.e9-18. doi: 10.1016/j.amjmed.2011.07.027. Epub 2012 Feb 2.

PMID:
22305579
13.

Altered dietary salt intake for preventing and treating diabetic kidney disease.

Suckling RJ, He FJ, Macgregor GA.

Cochrane Database Syst Rev. 2010 Dec 8;(12):CD006763. doi: 10.1002/14651858.CD006763.pub2. Review.

PMID:
21154374
14.

Serum adiponectin concentration is a positive predictor of all-cause and cardiovascular mortality in type 1 diabetes.

Forsblom C, Thomas MC, Moran J, Saraheimo M, Thorn L, Wadén J, Gordin D, Frystyk J, Flyvbjerg A, Groop PH; FinnDiane Study Group.

J Intern Med. 2011 Oct;270(4):346-55. doi: 10.1111/j.1365-2796.2011.02406.x. Epub 2011 Jun 23.

16.

Relation of reduction in urinary albumin excretion to ten-year cardiovascular mortality in patients with type 2 diabetes and systemic hypertension.

Estacio RO, Dale RA, Schrier R, Krantz MJ.

Am J Cardiol. 2012 Jun 15;109(12):1743-8. doi: 10.1016/j.amjcard.2012.02.020. Epub 2012 Mar 20.

PMID:
22440125
17.

Urine IgM-excretion as a prognostic marker for progression of type 2 diabetic nephropathy.

Tofik R, Torffvit O, Rippe B, Bakoush O.

Diabetes Res Clin Pract. 2012 Jan;95(1):139-44. doi: 10.1016/j.diabres.2011.10.008. Epub 2011 Nov 10.

PMID:
22078636
18.

Sodium intake and mortality in the NHANES II follow-up study.

Cohen HW, Hailpern SM, Fang J, Alderman MH.

Am J Med. 2006 Mar;119(3):275.e7-14.

PMID:
16490476
19.
20.

A prospective population-based study of microalbuminuria as a predictor of mortality in NIDDM.

Neil A, Hawkins M, Potok M, Thorogood M, Cohen D, Mann J.

Diabetes Care. 1993 Jul;16(7):996-1003.

PMID:
8359108

Supplemental Content

Support Center